[{"indications": "Indications\u00a0prophylaxis and treatment of allergic\r\nrhinitis", "name": "TRIAMCINOLONE ACETONIDE - CORTICOSTEROIDS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.2 Drugs acting on the nose", "12.2.1 Drugs used in nasal allergy", "Corticosteroids", "TRIAMCINOLONE ACETONIDE"], "cautions": "Cautions\u00a0\n(From Corticosteroids: British National Formulary)\nCautions\u00a0Corticosteroid nasal preparations should be avoided in the presence of untreated nasal infections, and also after nasal surgery (until healing has occurred); they should also be avoided in pulmonary tuberculosis. Patients transferred from systemic corticosteroids may experience exacerbation of some symptoms. Systemic absorption may follow nasal administration particularly if high doses are used or if treatment is prolonged; for cautions and side-effects of systemic corticosteroids, see section 6.3.2. The risk of systemic effects may be greater with nasal drops than with nasal sprays; drops are administered incorrectly more often than sprays. The height of children receiving prolonged treatment with nasal corticosteroids should be monitored; if growth is slowed, referral to a paediatrician should be considered.", "side-effects": "Side-effects\u00a0\n(From Corticosteroids: British National Formulary)\nSide-effects\u00a0Local side-effects include dryness, irritation of nose and throat, and epistaxis. Nasal ulceration has been reported, but occurs commonly with nasal preparations containing fluticasone furoate or mometasone furoate. Nasal septal perforation (usually following nasal surgery) occurs very rarely. Raised intra-ocular pressure or glaucoma may occur rarely. Headache, smell and taste disturbances may also occur. Hyperactivity, sleep disturbances, anxiety, depression, and aggression have been reported particularly in children. Hypersensitivity reactions, including bronchospasm, have been reported.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/60801.htm", "doses": ["adult and child over 12 years, 110\u00a0micrograms (2 sprays) into\r\neach nostril once daily; when control achieved, reduce to 55\u00a0micrograms\r\n(1 spray) into each nostril once daily; child 6\u201312 years, 55\u00a0micrograms (1 spray) into each nostril once daily,\r\nincreased if necessary to 110\u00a0micrograms (2 sprays) into each nostril\r\nonce daily; when control achieved, reduce to 55\u00a0micrograms (1 spray)\r\ninto each nostril once daily; max. duration of treatment 3 months; child 2\u20136 years see BNF for Children", "Preparations of triamcinolone acetonide can\r\nbe sold to the public for nasal administration as a non-pressurised\r\nnasal spray if supplied for the symptomatic treatment of seasonal\r\nallergic rhinitis in adults over 18 years, subject to max. daily dose\r\nof 110\u00a0micrograms per nostril for max. 3 months, and a pack size of\r\n3.575\u00a0mg"]}, {"indications": "Indications\u00a0prophylaxis and treatment of allergic\r\nrhinitis", "name": "TRIAMCINOLONE ACETONIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.2 Drugs acting on the nose", "12.2.1 Drugs used in nasal allergy", "Corticosteroids", "TRIAMCINOLONE ACETONIDE"], "cautions": "Cautions\u00a0\n(From Corticosteroids: British National Formulary)\nCautions\u00a0Corticosteroid nasal preparations should be avoided in the presence of untreated nasal infections, and also after nasal surgery (until healing has occurred); they should also be avoided in pulmonary tuberculosis. Patients transferred from systemic corticosteroids may experience exacerbation of some symptoms. Systemic absorption may follow nasal administration particularly if high doses are used or if treatment is prolonged; for cautions and side-effects of systemic corticosteroids, see section 6.3.2. The risk of systemic effects may be greater with nasal drops than with nasal sprays; drops are administered incorrectly more often than sprays. The height of children receiving prolonged treatment with nasal corticosteroids should be monitored; if growth is slowed, referral to a paediatrician should be considered.", "side-effects": "Side-effects\u00a0\n(From Corticosteroids: British National Formulary)\nSide-effects\u00a0Local side-effects include dryness, irritation of nose and throat, and epistaxis. Nasal ulceration has been reported, but occurs commonly with nasal preparations containing fluticasone furoate or mometasone furoate. Nasal septal perforation (usually following nasal surgery) occurs very rarely. Raised intra-ocular pressure or glaucoma may occur rarely. Headache, smell and taste disturbances may also occur. Hyperactivity, sleep disturbances, anxiety, depression, and aggression have been reported particularly in children. Hypersensitivity reactions, including bronchospasm, have been reported.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/60801.htm", "doses": ["adult and child over 12 years, 110\u00a0micrograms (2 sprays) into\r\neach nostril once daily; when control achieved, reduce to 55\u00a0micrograms\r\n(1 spray) into each nostril once daily; child 6\u201312 years, 55\u00a0micrograms (1 spray) into each nostril once daily,\r\nincreased if necessary to 110\u00a0micrograms (2 sprays) into each nostril\r\nonce daily; when control achieved, reduce to 55\u00a0micrograms (1 spray)\r\ninto each nostril once daily; max. duration of treatment 3 months; child 2\u20136 years see BNF for Children", "Preparations of triamcinolone acetonide can\r\nbe sold to the public for nasal administration as a non-pressurised\r\nnasal spray if supplied for the symptomatic treatment of seasonal\r\nallergic rhinitis in adults over 18 years, subject to max. daily dose\r\nof 110\u00a0micrograms per nostril for max. 3 months, and a pack size of\r\n3.575\u00a0mg"]}, {"indications": "Indications\u00a0severe inflammatory skin disorders such as eczemas\r\nunresponsive to less potent corticosteroids; psoriasis,\r\n\n(From 13.4 Topical corticosteroids: British National Formulary)\n13.4 Topical corticosteroids", "name": "TRIAMCINOLONE ACETONIDE - TOPICAL CORTICOSTEROIDS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.4 Topical corticosteroids"], "cautions": "Cautions\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nCautions\u00a0Avoid prolonged use of a topical corticosteroid on the face (and keep away from eyes). In children avoid prolonged use and use potent or very potent corticosteroids under specialist supervision; extreme caution is required in dermatoses of infancy including nappy rash\u2014treatment should be limited to 5\u20137 days.Psoriasis\u00a0The use of potent or very potent corticosteroids in psoriasis can result in rebound relapse, development of generalised pustular psoriasis, and local and systemic toxicity.", "side-effects": "Side-effects\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nSide-effects\u00a0Mild and moderately potent topical corticosteroids are associated with few side-effects but care is required in the use of potent and very potent corticosteroids. Absorption through the skin can rarely cause adrenal suppression and even Cushing\u2019s syndrome (section 6.3.2), depending on the area of the body being treated and the duration of treatment. Absorption is greatest where the skin is thin or raw, and from intertriginous areas; it is increased by occlusion. Local side-effects include:spread and worsening of untreated infection;thinning of the skin which may be restored over a period after stopping treatment but the original structure may never return;irreversible striae atrophicae and telangiectasia;contact dermatitis;perioral dermatitis;acne, or worsening of acne or rosacea;mild depigmentation which may be reversible;hypertrichosis also reported.In order to minimise the side-effects of a topical corticosteroid, it is important to apply it thinly to affected areas only, no more frequently than twice daily, and to use the least potent formulation which is fully effective.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5928.htm", "doses": ["Apply thinly 1\u20132 times daily"]}, {"indications": "Indications\u00a0severe inflammatory skin disorders such as eczemas\r\nunresponsive to less potent corticosteroids; psoriasis,\r\n\n(From 13.4 Topical corticosteroids: British National Formulary)\n13.4 Topical corticosteroids", "name": "TRIAMCINOLONE ACETONIDE With antimicrobials", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "13 Skin", "13.4 Topical corticosteroids", "TRIAMCINOLONE ACETONIDE", "With antimicrobials"], "cautions": "Cautions\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nCautions\u00a0Avoid prolonged use of a topical corticosteroid on the face (and keep away from eyes). In children avoid prolonged use and use potent or very potent corticosteroids under specialist supervision; extreme caution is required in dermatoses of infancy including nappy rash\u2014treatment should be limited to 5\u20137 days.Psoriasis\u00a0The use of potent or very potent corticosteroids in psoriasis can result in rebound relapse, development of generalised pustular psoriasis, and local and systemic toxicity.", "side-effects": "Side-effects\u00a0\n(From 13.4 Topical corticosteroids: British National Formulary)\nSide-effects\u00a0Mild and moderately potent topical corticosteroids are associated with few side-effects but care is required in the use of potent and very potent corticosteroids. Absorption through the skin can rarely cause adrenal suppression and even Cushing\u2019s syndrome (section 6.3.2), depending on the area of the body being treated and the duration of treatment. Absorption is greatest where the skin is thin or raw, and from intertriginous areas; it is increased by occlusion. Local side-effects include:spread and worsening of untreated infection;thinning of the skin which may be restored over a period after stopping treatment but the original structure may never return;irreversible striae atrophicae and telangiectasia;contact dermatitis;perioral dermatitis;acne, or worsening of acne or rosacea;mild depigmentation which may be reversible;hypertrichosis also reported.In order to minimise the side-effects of a topical corticosteroid, it is important to apply it thinly to affected areas only, no more frequently than twice daily, and to use the least potent formulation which is fully effective.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5933.htm", "doses": ["Apply thinly 1\u20132 times daily", "Name[Aureocort\u00ae (Goldshield) ] Ointment, triamcinolone acetonide 0.1%, chlortetracycline  hydrochloride 3%, in an anhydrous greasy basis containing wool fat\r\nand white soft paraffin, net price 15\u00a0g = \u00a33.51. \r\n    Label:\r\n    28, counselling, application. Potency: potentExcipients  include wool fatNote\u00a0Stains clothing"]}]